Genetron Health to Present at Upcoming Investor Conferences
BEIJING, April 22, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that management will present and host one-on-one meetings at three upcoming investor conferences.
Details related to the management team’s participation are as follows:
Conference: UBS Virtual Healthcare Summit
Location: Virtual
Dates: April 28-29, 2021
Conference: Soochow Securities, “Innovative Medical Device Corporate Summit”
Location: Shanghai
Dates: April 30, 2021
Presentation: Chief Medical Officer, Dr. Yun-Fu Hu will present on April 30, 2021
Conference: CICC Healthcare Industry Forum 2021, “Innovation Drives Growth, Quality Drives Consumption”
Location: Shanghai
Dates: May 18-19, 2021
Presentation: Co-Founder and CEO, Sizhen Wang will present on May 18, 2021
Interested parties may request more information by contacting their sales representatives at UBS, Soochow Securities, and CICC.
About Genetron Holdings Limited
Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq:GTH) is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive oncology portfolio that covers the entire spectrum of cancer management, addressing needs and challenges from early screening, diagnosis and treatment recommendations, as well as continuous disease monitoring and care. Genetron Health also partners with global biopharmaceutical companies and offers customized services and products. For more information, please visit .
Safe Harbor Statement
This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. In some cases, forward-looking statements can be identified by words or phrases such as “may”, “will,” “expect,” “anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any duty to update such information, except as required under applicable law.
Investor Relations Contact
US:
Hoki Luk
Head of Investor Relations
Email:
Phone: +1 (408) 891-9255
David Deuchler, CFA
Managing Director | Gilmartin Group
Email:
